Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001689548-25-000092
Filing Date
2025-08-04
Accepted
2025-08-04 08:33:42
Documents
65
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q prax-20250630.htm   iXBRL 10-Q 977418
2 EX-31.1 exhibit31120250630.htm EX-31.1 12839
3 EX-31.2 exhibit31220250630.htm EX-31.2 14138
4 EX-32.1 exhibit32120250630.htm EX-32.1 13131
  Complete submission text file 0001689548-25-000092.txt   5602676

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prax-20250630.xsd EX-101.SCH 41547
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prax-20250630_cal.xml EX-101.CAL 60308
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prax-20250630_def.xml EX-101.DEF 182390
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prax-20250630_lab.xml EX-101.LAB 549884
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prax-20250630_pre.xml EX-101.PRE 362824
67 EXTRACTED XBRL INSTANCE DOCUMENT prax-20250630_htm.xml XML 712609
Mailing Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110 617-300-8460
Praxis Precision Medicines, Inc. (Filer) CIK: 0001689548 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39620 | Film No.: 251178212
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)